home / stock / jan / jan news


JAN News and Press, JanOne Inc. From 09/03/20

Stock Information

Company Name: JanOne Inc.
Stock Symbol: JAN
Market: NYSE
Website: janone.com

Menu

JAN JAN Quote JAN Short JAN News JAN Articles JAN Message Board
Get JAN Alerts

News, Short Squeeze, Breakout and More Instantly...

JAN - JanOne confirms stability data of JAN101 development batch and prepares for commercial GMP production to support the upcoming PAD and potential Covid-19 clinical trials

LAS VEGAS , Sept. 3, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing  treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has confirmed stability of its developmental batch run of JAN101.  Work...

JAN - LD Micro - 360 Companies - Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

JAN - JanOne Selects Partner for Bottling and Labeling of JAN101 for Peripheral Artery Disease and Potential Covid-19 Clinical Trials

LAS VEGAS , Aug. 28, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has chosen its bottling and labeling partner to support upcoming clinical tri...

JAN - Are COVID-19 Vaccines And Therapeutics Advancing Faster Than Expected

August 26, 2020 Palm Beach, FL – August 26, 2020 – The worldwide response, both private and public, to finding a therapeutic and/or vaccine for the global pandemic has brought out the best in the global community. Contrary to historical comparable situations, it appe...

JAN - JanOne Advances its Potential Peripheral Artery Disease and Covid-19 Vascular Inflammation Treatment Towards Trial Readiness

LAS VEGAS , Aug. 26, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has successfully completed its initial engineering batch of JAN101. The JAN101 for...

JAN - JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript

JanOne Inc. (JAN) Telebriefing and Corporate Update Call August 25, 2020 16:15 ET Corporate Participants Tony Isaac - Chief Executive Officer Tony Giordano - Chief Scientific Officer Amol Soin - Chief Medical Officer Conference Call Participants Jeremy Roe - Integra Rober...

JAN - JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Potential Applications for COVID-19 Vascular Complications

LAS VEGAS , Aug. 21, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that it intends to provide a public business update via teleconfer...

JAN - JanOne to Present at The LD 500 Virtual Conference

LAS VEGAS , Aug. 19, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties,   today announced that it will be presenting at the 12 th Ann...

JAN - JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials

LAS VEGAS , Aug. 11, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, together with its manufacturing partner, has successfully completed t...

JAN - GRPN, CNDT, AYX and CAPR among midday movers

Gainers:  Conduent (NASDAQ: CNDT ) +75% . More news on: Conduent Incorporated, OpGen, Inc., Groupon, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10